Frank X. Leonard, President, CNS Cancers US at NovoCure Ltd (NVCR), sold 21,215 shares at $76.16 ($1.6M) on 2023-03-03, disclosed to the SEC on 2023-03-07.
Open-market sale of $1.6M NVCR by President, CNS Cancers US. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $76.16 | 4,403 | $335K | 20.9% |
| 2 | $76.16 | 888 | $68K | 4.2% |
| 3 | $76.16 | 4,403 | $335K | 20.9% |
| 4 | $76.16 | 888 | $68K | 4.2% |
| 5 | $75.00 | 6,003 | $450K | 28.0% |
| 6 | $75.59 | 2,315 |
| $175K |
| 10.9% |
| 7 | $75.59 | 2,315 | $175K | 10.9% |
| Total | $75.71 avg | 21,215 | $1.6M | 100% |
| Filing → |
| NVCR | SELL | 2026-03-03 | $231K | — | Filing → |
| NVCR | SELL | 2025-06-04 | $1.0M | — | Filing → |
| NVCR | SELL | 2025-03-04 | $47K | — | Filing → |